Russell Investments Group, Ltd.

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1692234 Seattle, WA

Position in ACRS

as of Jun 30, 2026 · filed Aug 6, 2026 Compact

Position Value

$1,931,138

+$775,521 QoQ

Shares Held

365,055

+18.5% QoQ

Ownership

0.248%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#42

of 149 holders

Holding Since

Sep 2023

12 quarters on record

Voting authority Sole 89% Shared 0% None 11%

Healthcare · as of Jun 30, 2026

Russell Investments Group, Ltd. holds $1,504,360,847 across 308 Biotechnology names. ACRS ranks #90 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	336,990	$167,393,033
2	REGN	Regeneron Pharmaceuticals, Inc.	230,151	$143,508,345
3	RPRX	Royalty Pharma plc	1,694,250	$94,996,587
4	INCY	Incyte Corp	425,616	$48,247,822
5	ALNY	Alnylam Pharmaceuticals, Inc.	158,228	$47,631,369
6	BMRN	Biomarin Pharmaceutical Inc	783,148	$44,811,725
7	LGND	Ligand Pharmaceuticals Inc	120,304	$38,026,888
8	PTCT	Ptc Therapeutics, Inc.	418,025	$34,098,295

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,931,138	365,055	+18.5%	Shares	Defined	2026-08-06
2026-03-31	$1,155,617	308,165	+3049.4%	Shares	Defined	2026-05-08
2025-12-31	$29,452	9,785	+1.8%	Shares	Defined	2026-02-17
2025-09-30	$18,262	9,612	+1195.4%	Shares	Defined	2025-11-13
2025-06-30	$1,053	742	-64.6%	Shares	Defined	2025-08-13
2025-03-31	$3,203	2,094	-24.3%	Shares	Defined	2025-05-13
2024-12-31	$6,857	2,765	0.0%	Shares	Defined	2025-02-13
2024-09-30	$3,179	2,765	-22.1%	Shares	Defined	2024-11-13
2024-06-30	$3,905	3,550	-94.3%	Shares	Defined	2024-08-08
2024-03-31	$77,836	62,772	+5265.1%	Shares	Defined	2024-05-08
2023-12-31	$1,228	1,170	+3445.5%	Shares	Defined	2024-02-05
2023-09-30	$226	33	—	Shares	Defined	2023-11-13
No filing history on record for this holder in this stock.